ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1875

Assessment of Structural Damage of the Thumb Base in Patients with Hand Osteoarthritis: Comparing the Newly Developed Omeract Magnetic Resonance Imaging Scoring System with Standard Radiography

S. van Beest1, F.P.B. Kroon1, W. Damman1, R. Liu1, H.M. Kroon2 and M. Kloppenburg3, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Hand disorders, Magnetic resonance imaging (MRI), Osteoarthritis, outcome measures and radiography

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Imaging of Rheumatic Diseases I: Novel Imaging and Scoring Systems

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Thumb base osteoarthritis (OA) is characterized by structural damage, most commonly evaluated by radiography. However radiography is insensitive. Magnetic resonance (MR) imaging could be a valuable alternative, however a standardized scoring method for thumb base MR images did not exist until recently OMERACT developed the thumb base OA MRI scoring system (TOMS). Our aim was to investigate the validity of the new TOMS by comparing TOMS scores with radiographic scores.

Methods: Two hundred patients (83.5% women, median age 60.5 years) with primary hand OA (90.5% fulfilling ACR classification criteria) from the rheumatology outpatient clinic, who had dorsopalmar radiographs and MR scans of the right thumb base, were studied. T1- and fat suppressed T2-turbo spin weighted sequences were obtained on a 1.5 Tesla scanner. Radiographs of the first carpometacarpal (CMC1) and scaphotrapeziotrapezoid (STT) joints were scored using the OARSI atlas (osteophytes and joint space narrowing [JSN] in CMC1: 0-3 and STT: absent/present) in consensus by two readers with good intra-reader reliability. MR images were scored using TOMS (osteophytes in CMC1: 0-6 and STT: 0-9; cartilage space loss [CSL] for both joints: 0-3) by two readers, with good intra- and inter-reader reliability. For analysis we used the average of both readers. Readers were blinded for clinical and other imaging data. To study validity, the distribution of the TOMS scores for osteophytes and CSL were described stratified for the different radiographic stages for osteophytes and JSN, respectively.

Results: On MR images osteophytes were detected in the vast majority of thumb bases (CMC1 n=172; STT n=102). The score of TOMS increased with more severe radiographic stages (see figures). However, the number of patients without any osteophytes in both CMC1 and STT was considerably lower for TOMS (n=19) than for the OARSI (n=105) scoring. A similar difference was apparent for absence of CSL (n=82) versus JSN (n=107) in both CMC1 and STT. Patients with isolated STT osteophytes were quite rare for both TOMS (n=9) and the OARSI (n=1) scoring. The most prominent discrepancy between TOMS and OARSI sensitivity was found for osteophytes: an additional 170 joints (CMC1 n=79; STT n=91) were found positive with TOMS, while only 1 OARSI-positive CMC1 scored negative with TOMS.

Conclusion: Scores of OA features assessed on MR images by TOMS were correlated with radiographic scores, indicating good validity of the TOMS. Furthermore, the frequencies of positive features assessed on MR images were higher compared to those on radiographs, suggesting high sensitivity for the TOMS.

 


 


Disclosure: S. van Beest, Innovative Medicines Initiative: Approach, 2; F. P. B. Kroon, None; W. Damman, None; R. Liu, None; H. M. Kroon, None; M. Kloppenburg, Pfizer, 2,AbbVie, GlaxoSmithKline, Merck, Levicept, 5,Dutch Arthritis Fund, 2,Innovative Medicines Initiative: APPROACH, 2.

To cite this abstract in AMA style:

van Beest S, Kroon FPB, Damman W, Liu R, Kroon HM, Kloppenburg M. Assessment of Structural Damage of the Thumb Base in Patients with Hand Osteoarthritis: Comparing the Newly Developed Omeract Magnetic Resonance Imaging Scoring System with Standard Radiography [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/assessment-of-structural-damage-of-the-thumb-base-in-patients-with-hand-osteoarthritis-comparing-the-newly-developed-omeract-magnetic-resonance-imaging-scoring-system-with-standard-radiography/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-structural-damage-of-the-thumb-base-in-patients-with-hand-osteoarthritis-comparing-the-newly-developed-omeract-magnetic-resonance-imaging-scoring-system-with-standard-radiography/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology